Methods for improving drug efficacy including a combination of drug administration and nerve modulation

1. A method for treating a patient having an obstructive lung disease, comprising:

(a) disrupting nerve activity in a parasympathetic nervous system of the patient to reduce obstruction in a distal airway in a lung of the patient; and

(b) while nerve activity is disrupted and the obstruction is reduced in the distal airway, administering a dose of an anticholinergic drug to the patient, the anticholinergic drug having a reference efficacy,

wherein a combination of steps (a) and (b) have a combined treatment efficacy greater than the reference efficacy of the anticholinergic drug.

2. The method of claim 1 , wherein step (a) comprises stimulating a portion of the parasympathetic nervous system with electrical impulses to block nervous system signals from traveling past the portion of the parasympathetic nervous system.

3. The method of claim 1 , wherein the anticholinergic drug is an inhaled drug.

4. The method of claim 1 , wherein the anticholinergic drug is a non-inhaled drug.

5. The method of claim 1 , wherein obstruction in the distal airway results from smooth muscle contraction, thickening of airway wall, mucous accumulation, or a combination thereof.

6. The method of claim 1 , wherein the patient suffers from chronic obstructive pulmonary disease (COPD).

7. The method of claim 1 , wherein the patient suffers from asthma.

8. The method of claim 1 , wherein the patient suffers from cystic fibrosis.

9. The method of claim 1 , wherein step (a) is performed without causing permanent damage to non-nerve tissue.

10. The method of claim 1 , wherein step (a) comprises attenuating nerve activity in a portion of the parasympathetic nervous system of the patient.

11. The method of claim 1 , wherein step (a) comprises stimulating nerve activity in a portion of the sympathetic nervous system of the patient.

12. The method of claim 1 , wherein step (a) comprises disrupting activity in a nerve of a first airway of the patient which carries signals to or from the distal airway, wherein the distal airway is a higher generation airway of the first airway.

13. The method of claim 1 , wherein step (a) comprises disrupting nerve activity of a pulmonary plexus.

14. The method of claim 1 , wherein step (a) comprises disrupting nerve activity of a bronchial branch of the vagus nerve.

15. The method of claim 1 , wherein step (a) comprises damaging a portion of the parasympathetic nervous system.

16. The method of claim 15 , wherein damaging the portion of the parasympathetic nervous system comprises applying energy to the portion of the parasympathetic nervous system.

17. The method of claim 16 , wherein applying energy to the portion of parasympathetic nervous system comprises applying thermal energy, microwave, electrical energy, cryogenic energy, acoustic energy, radio frequency energy, pulsed high voltage energy, mechanical energy, ionizing radiation, or optical energy to the portion of the parasympathetic nervous system.

18. The method of claim 16 , wherein applying energy to the portion of parasympathetic nervous system does not cause permanent damage to any interior airway walls of the patient.

19. The method of claim 16 , further comprising protecting an interior airway wall of the patient from permanent damage while applying the energy.

20. The method of claim 1 , wherein step (a) comprises damaging a nerve trunk extending along a wall of an airway.

21. The method of claim 20 , wherein step (a) comprises damaging a bronchial branch of the vagus nerve.

22. The method of claim 20 , wherein the nerve trunk is damaged by delivering energy from an interventional device.

23. The method of claim 22 , wherein the energy is delivered from within the airway.

24. The method of claim 22 , wherein the energy is delivered from outside the airway.